May 24, 2022

Kidney Research Institute

de Boer

The Kidney Research Institute (KRI) has named Ian de Boer as its new director. He becomes only the second director in the KRI's 14-year history, following the departure of founding director Jonathan Himmelfarb. de Boer has served as associate director of the KRI since 2016. He is recognized worldwide for his expertise in diabetic kidney disease and vitamin D metabolism, as well as a sought-after research collaborator and speaker. He currently serves as deputy editor of the Clinical Journal of American of Nephrology and is co-chair of the international KDIGO Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. In addition to his own research, de Boer has been an active mentor to many training in Nephrology. He attended medical school at Oregon Health & Science University and completed his residency at the University of California San Francisco, where he was named outstanding third-year medical resident. The KRI was established in 2008 as a collaboration between UW Medicine and Northwest Kidney Centers with the mission to conduct research to improve the lives of people with kidney disease. In the years since, the KRI has become recognized worldwide for a wide range of high-impact patient-oriented research, the application of innovative technology, and advances in person-centered care for people living with kidney disease. Founded in Seattle in 1962, Northwest Kidney Centers is a regional, not-for-profit, community-based provider of kidney dialysis, public health education and research into the causes and treatments of chronic kidney disease.